• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人造血液或替代血液取代天然血液的研究。

Investigation on artificial blood or substitute blood replace the natural blood.

作者信息

Keyhanian Sh, Ebrahimifard M, Zandi M

机构信息

Associate Professor of Oncologist, Islamic Azad University of Tonekabon, Tonekabon, Iran.

Young Researchers and Elite Club, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran.

出版信息

Iran J Ped Hematol Oncol. 2014;4(2):72-7. Epub 2014 Apr 20.

PMID:25002929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4083204/
Abstract

Blood is a liquid tissue in which dissolved with abundant chemical factors and millions of different cells The reduction of unwanted side effects, especially diseases that emerge through blood such as HIV and hepatitis, has a significant role for modern medicine of transfusion and transplantation. The issues and costs of human blood collection and storage, direct this procedure towards the use of alternatives blood. Two important research fields of this area were oxygen carriers based on hemoglobin and perfluoro chemicals. While they do not have the same quality as the blood cell products, the oxygen carrier solutions have potential clinical and non-clinical applications. The result showed that these products can reach to the body tissues easier than normal red blood cells, and can control the oxygen directly. The final aim of transfusion is to establish a transfusion system with no side effects, and the fact that oxygen carrier artificial blood has this property. The article attempts to step towards solving some problems of blood transfusion through describing the properties of artificial blood alternatives.

摘要

血液是一种液体组织,其中溶解有丰富的化学因子和数百万种不同的细胞。减少不必要的副作用,尤其是通过血液传播的疾病,如艾滋病毒和肝炎,对现代输血和移植医学具有重要意义。人类血液采集和储存的问题及成本,促使这一过程朝着使用替代血液的方向发展。该领域的两个重要研究方向是基于血红蛋白的氧载体和全氟化合物。虽然氧载体溶液的质量不如血细胞产品,但它们具有潜在的临床和非临床应用。结果表明,这些产品比正常红细胞更容易到达身体组织,并且可以直接控制氧气。输血的最终目标是建立一个无副作用的输血系统,而氧载体人工血液具有这一特性。本文试图通过描述人工血液替代品的特性,朝着解决输血中的一些问题迈出一步。

相似文献

1
Investigation on artificial blood or substitute blood replace the natural blood.对人造血液或替代血液取代天然血液的研究。
Iran J Ped Hematol Oncol. 2014;4(2):72-7. Epub 2014 Apr 20.
2
Artifical Blood.人造血液
Med J Armed Forces India. 2003 Jan;59(1):45-50. doi: 10.1016/S0377-1237(03)80107-7. Epub 2011 Jul 21.
3
[Autologous transfusion - from euphoria to reason: clinical practice based on scientific knowledge. (Part IV). Artificial oxygen carriers: cell-free hemoglobin solutions -- current status 2004].[自体输血——从狂热到理性:基于科学知识的临床实践。(第四部分)人工氧载体:无细胞血红蛋白溶液——2004年现状]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2005 Jan;40(1):38-45. doi: 10.1055/s-2004-825914.
4
[Artificial oxygen carriers. Alternatives to homologous blood transfusion?].[人工氧载体。同种异体输血的替代方法?]
Zentralbl Chir. 1999;124(4):260-70.
5
6
Artificial oxygen carriers.人工氧载体
Eur J Anaesthesiol. 1998 Sep;15(5):571-84. doi: 10.1046/j.1365-2346.1998.00356.x.
7
[Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions].[输血用氧载体的当前研究:血红蛋白溶液与氟碳乳剂]
Ann Pharm Fr. 1992;50(5-6):250-66.
8
Artificial O2 carriers: status in 2005.人工氧载体:2005年的现状
Curr Pharm Des. 2005;11(31):4099-114. doi: 10.2174/138161205774913354.
9
[Artificial oxygen carriers as an alternative to red blood cell transfusion].[人工氧载体作为红细胞输血的替代物]
Anaesthesist. 2005 Aug;54(8):741-54. doi: 10.1007/s00101-005-0893-3.
10
An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends.与红细胞输血相关的未解决的固有问题概述以及人工氧载体和工程化红细胞的潜在用途:现状/未来趋势
Transfus Apher Sci. 2007 Dec;37(3):251-9. doi: 10.1016/j.transci.2007.02.007. Epub 2007 Nov 26.

引用本文的文献

1
A quantitative analysis of the factors that influence clinical blood demand in the Suzhou area.苏州地区临床用血需求影响因素的定量分析。
Sci Rep. 2025 Jul 1;15(1):20879. doi: 10.1038/s41598-025-05685-8.
2
In vitro erythropoiesis: the emerging potential of induced pluripotent stem cells (iPSCs).体外红细胞生成:诱导多能干细胞(iPSC)的新潜力。
Blood Sci. 2024 Dec 26;7(1):e00215. doi: 10.1097/BS9.0000000000000215. eCollection 2025 Jan.
3
Forecasting blood demand for different blood groups in Shiraz using auto regressive integrated moving average (ARIMA) and artificial neural network (ANN) and a hybrid approaches.使用自回归积分移动平均 (ARIMA) 和人工神经网络 (ANN) 以及混合方法预测设拉子不同血型的血液需求。
Sci Rep. 2022 Dec 20;12(1):22031. doi: 10.1038/s41598-022-26461-y.
4
Blood Particulate Analogue Fluids: A Review.血液微粒模拟液:综述
Materials (Basel). 2021 May 9;14(9):2451. doi: 10.3390/ma14092451.
5
Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes.人诱导多能干细胞系库用于稀有血型红细胞的生产。
J Transl Med. 2020 Jun 12;18(1):236. doi: 10.1186/s12967-020-02403-y.
6
Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor.围手术期输血触发评分在恶性肿瘤手术治疗患者中的应用
Indian J Hematol Blood Transfus. 2020 Jan;36(1):156-163. doi: 10.1007/s12288-019-01180-z. Epub 2019 Sep 12.

本文引用的文献

1
Artifical Blood.人造血液
Med J Armed Forces India. 2003 Jan;59(1):45-50. doi: 10.1016/S0377-1237(03)80107-7. Epub 2011 Jul 21.
2
Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.纳米生物技术工程血红蛋白和血红蛋白纳米胶囊的血液替代。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jul-Aug;2(4):418-30. doi: 10.1002/wnan.95.
3
Setbacks in blood substitutes research and development: a biochemical perspective.血液替代品研发中的挫折:生化视角
Clin Lab Med. 2010 Jun;30(2):381-9. doi: 10.1016/j.cll.2010.02.009. Epub 2010 May 6.
4
Artificial oxygen carriers as a possible alternative to red cells in clinical practice.人工氧载体作为临床实践中红细胞的一种可能替代物。
Sao Paulo Med J. 2009 May;127(2):97-100. doi: 10.1590/s1516-31802009000200008.
5
HBOC-201: the multi-purpose oxygen therapeutic.HBOC - 201:多功能氧疗剂。
EuroIntervention. 2008 May;4(1):161-5. doi: 10.4244/eijv4i1a26.
6
Effects of PEG-PLA-nano artificial cells containing hemoglobin on kidney function and renal histology in rats.含血红蛋白的聚乙二醇-聚乳酸纳米人工细胞对大鼠肾功能和肾脏组织学的影响。
Artif Cells Blood Substit Immobil Biotechnol. 2008;36(5):421-30. doi: 10.1080/10731190802369763.
7
HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.HBOC-201作为输血替代品:在择期骨科手术多中心III期试验中的疗效和安全性评估
J Trauma. 2008 Jun;64(6):1484-97. doi: 10.1097/TA.0b013e318173a93f.
8
Enhancing stability and expression of recombinant human hemoglobin in E. coli: Progress in the development of a recombinant HBOC source.增强重组人血红蛋白在大肠杆菌中的稳定性和表达:重组血红蛋白氧载体来源开发的进展
Biochim Biophys Acta. 2008 Oct;1784(10):1471-9. doi: 10.1016/j.bbapap.2008.04.012. Epub 2008 May 1.
9
Hemoglobin oxygen fractional saturation regulates nitrite-dependent vasodilation of aortic ring bioassays.血红蛋白氧分数饱和度调节主动脉环生物测定中依赖亚硝酸盐的血管舒张。
Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2565-72. doi: 10.1152/ajpheart.00759.2007. Epub 2007 Aug 31.
10
Artificial oxygen carriers: a current review.人工氧载体:当前综述
AANA J. 2007 Jun;75(3):205-11.